Home » Topics » BioWorld Science

BioWorld Science
RSS

Enrollment under way in phase I study of NQO2 anticancer therapy

May 26, 2004

Studies show pregabalin to be safe and effective in treating postherpetic neuralgia

May 26, 2004

Efficacy and pharmacokinetics of Oxytrex in patients with chronic osteoarthritic pain

May 26, 2004

Further data on DepoMorphine in postoperative pain control

May 26, 2004

Novel inducible nitric oxide synthase inhibitor promising against graft rejection

May 26, 2004

Combination of CCR5 receptor antagonist and ciclosporin effective against allograft rejection

May 26, 2004

Efficacy and safety of tacrolimus in fistulizing Crohn's disease

May 26, 2004

Activity of LBM-415 extensively investigated

May 25, 2004

New neurotrophic agents and their use in Parkinson's disease, ALS, stroke, etc.

May 25, 2004

New stilbene-based immunomodulators prepared and tested at Welichem

May 25, 2004

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...